These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 3782799
1. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis. Morgan BP, Dankert JR, Esser AF. J Immunol; 1987 Jan 01; 138(1):246-53. PubMed ID: 3782799 [Abstract] [Full Text] [Related]
8. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9. Carney DF, Koski CL, Shin ML. J Immunol; 1985 Mar 01; 134(3):1804-9. PubMed ID: 3968432 [Abstract] [Full Text] [Related]
12. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW. J Immunol; 1994 Sep 01; 153(5):2213-21. PubMed ID: 8051421 [Abstract] [Full Text] [Related]
13. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis. Pilzer D, Fishelson Z. Int Immunol; 2005 Sep 01; 17(9):1239-48. PubMed ID: 16091382 [Abstract] [Full Text] [Related]
14. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. J Immunol; 1983 Nov 01; 131(5):2570-5. PubMed ID: 6355297 [Abstract] [Full Text] [Related]
15. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore. Bhakdi S, Tranum-Jensen J. J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488 [Abstract] [Full Text] [Related]
16. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8. Lehto T, Meri S. J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959 [Abstract] [Full Text] [Related]
17. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin. Brahmi Z, Csipo I, Bochan MR, Su B, Montel AH, Morse PA. Nat Immun; 1995 Sep 01; 14(5-6):271-85. PubMed ID: 8933821 [Abstract] [Full Text] [Related]
19. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J, Meri S. Lab Invest; 1994 Dec 01; 71(6):820-7. PubMed ID: 7528832 [Abstract] [Full Text] [Related]
20. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. Hu VW, Esser AF, Podack ER, Wisnieski BJ. J Immunol; 1981 Jul 01; 127(1):380-6. PubMed ID: 7240749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]